Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-08-013002
Filing Date
2008-02-22
Accepted
2008-02-22 17:06:38
Documents
1
Period of Report
2008-02-21

Document Format Files

Seq Description Document Type Size
1 rrd196640.html 4  
1 rrd196640.xml 4 2961
  Complete submission text file 0001181431-08-013002.txt   4724
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Issuer) CIK: 0000811641 (see all company filings)

EIN.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address IMMUCELL CORP 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 2078782770
CRABB JOSEPH H (Reporting) CIK: 0001136546 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-12934 | Film No.: 08637237